|
| Spectrum of Diseases/Conditions Written Requests (3/22/2000) CDER report
|   |
Office of Generic Drugs Page This area has information for consumers and industry about generic drug products. Check this area for updates, changes, and announcements.
|   |
National Drug Code Directory CDER Document: The NDC serves as a universal product identifier for human drugs. The current edition of the National Drug Code Directory is limited to prescription drugs and a few selected OTC products
|   |
Medicines Control Agency: United Kingdom Licensing, quality inspection and enforcement.
|   |
New and Generic Drug Approvals This newly approved or tenatively approved drug listing is an interim page intended to provide timely information on new drug products as a more comprehensive page is developed.
|   |
National Science Foundation (NSF) Arlington, Virginia based independent US government agency responsible for promoting science and engineering through programs that invest over $3.3 billion per year in almost 20,000 research and education projects in science and engineering.
|   |
Center for Disease Control (CDC) Database of legislation regarding disease control, publications, health topics, news releases.
|   |
Orange Book Approved Drug Products with Therapeutic Equivalence Evaluations: searchable by active ingredients, or by applicant holder
|   |
FDA - Import Alerts Developed to communicate guidance to FDA field offices. The purpose of an Import Alert is to identify and disseminate import information (problems, violative trends, etc.) to FDA personnel thus providing for more uniform and effective import cov.
|   |
National Institutes of Health (NIH) Consensus Development Program
|   |
Inactive Ingredient Guide Contains all inactive ingredients present in approved drug products or conditionally approved drug products currently marketed for human use.
|   |
National Center for Complementary and Alternative Medicine - NCCAM - National Institutes of Health - NIH The Congressional mandate establishing the NCCAM stated that the Center's purpose is to 'facilitate the evaluation of alternative medical treatment modalities' to determine their effectiveness
|   |
U.S. Department of Health and Human Services THE DEPARTMENT OF HEALTH AND HUMAN SERVICES is the United States government's principal agency for protecting the health of all Americans and providing essential human services, especially for those who are least able to help themselves.
|   |
Canadian Health Network A federal government department, encourages the health of Canadians through promotion and prevention activities, and supports the health system through research funding and the support of provincial/territorial health systems.
|   |
The Cooperative Human Linkage Center Links to maps, markers, publications, and related information.
|   |
Conformance Review Checklist for NDAs FDA document in PDF format
|   |
FDA Public Health Advisory Risk of Drug Interactions with St. John's Wort and Indinavir and Other Drugs
|   |
Pediatric Cancer Therapeutics: Letter of Interest (2/15/2000) CDER document on cancer therapeutics
|   |
World Health Organization (WHO/OMS) Official site of the United Nations' international organization working for the highest possible level of health, defined as a state of complete physical, mental and social well-being and not merely the absence of disease or infirmity.
|   |
Agency for Healthcare Research and Quality Formerly the Agency for Health Care Policy and Research, this agency provides practical health care information, research findings, and data to help consumers, health providers, health insurers, researchers, and policymakers make informed decisi.
|   |
The 106th Congress Online pharmacy investigation summary.
|   |
Medwatch MedWatch, the FDA Medical Products Reporting Program, is an initiative designed both to educate all health professionals about the critical importance of being aware of, monitoring for, and reporting adverse events and problems to FDA and/or the.
|   |
Labeling Review Branch Office of Generic Drugs, Division of Labeling and Program. The purpose of this page is to provide information on recently approved labeling changes for Reference Listed Drug (RLD) products.
|   |
FDA U.S. Food and Drug Administration (FDA)homepage
|   |
ClinicalTrials.Gov The U.S. National Institutes of Health, through its National Library of Medicine, has developed ClinicalTrials.gov to provide patients, family members and members of the public current information about clinical research studies
|   |
US National Institute of Standards and Technology (NIST) A federal technology agency that works with industry to develop and apply technology, measurements, and standards.
|   |
FDA - Report Problems/IssuesFederal Register, The Reports of adverse reactions categorized by product type, health alerts, and recalls
|   |
Tentative Advisory Committee Meetings: 2000 (updated 4/3/2000) CDER: The following dates have been set aside by CDER advisory committees for possible future meetings. The subject matter and location of the meetings to be published in the Federal Register in the month prior to the meeting date
|   |
FDA Talk Paper Prepared by the Press Office to guide FDA personnel in responding with consistency and accuracy to questions from the public on subjects of current interest
|   |
Center for Drug Evaluation and Research(CDER) A division of FDA, site contains drug information, regulatory guidance, CDER archives and calendar.
|   |
National Women's Health Information Center A service of the Office on Women’s Health in the Department of Health and Human Services. The NWHIC provides a gateway to the vast array of Federal and other women’s health information resources.
|   |
Program Support Center An Operating Division (OPDIV) within the Department of Health and Human Services (HHS). Our mission is to provide qualitative and responsive 'support services' on a cost-effective, competitive, 'service-for-fee' basis to HHS components and othe.
|   |
WHO: Office of World Health Report The report is published by the World Health Organization
|   |
World Medical Association The World Medical Association (WMA) is an international organization representing physicians
|   |
Approved Drug Products with Therapeutic Equivalence Evaluations Prepared By Division of Data Management and Services Office of Information Technology Center for Drug Evaluation and Research, FDA
|   |
Electronic Regulatory Submissions and Review (Updated 2/22/2000) This page provides information about the electronic submission of regulatory information to the Center and the review of it by CDER staff. Additional guidance documents, when available in draft or final form, will be added to this page.
|   |
National Cancer Institute (NCI) Website provides cancer information, resources for scientists, information about partnerships and NCI, recent news and links to its divisions.
|   |
INDs Received CDER Report: Calendar Years 1986-1999 (Updated 2/15/2000)
|   |
Efficacy Supplements Approved in Calendar Year 1999 (Posted 3/1/2000) CDER Document
|   |
FDA-CDER This area includes meetings and events that are related to CDER's mission
|   |
FDA - Disqualified/Restricted/Assurances List for Clinical Investigators Names of all investigators that the FDA has at one time disqualified, restricted, or required assurances in their use of investigational products.
|   |
National Institutes of Health(NIH) An agency of the U.S. Department of Health and Human Services, the NIH is the Federal focal point for health research, conducting research in its own laboratories; supporting the research of non-Federal scientists in universities, medical school.
|   |
National Center for Health Statistics NCHS is the principal vital and health statistics agency of the US government. A comprehensive resource with links to various surveys, tabulated state data, and more.
|   |
Bioresearch Monitoring Information System File Information submitted to FDA identifying clinical investigators (CIs), contract research organizations (CROs), and institutional review boards (IRBs) involved in the conduct of Investigational New Drug (IND) studies with human investigational dr.
|   |
Center for Biologics Evaluation and Research (CBER) Regulatory science, publicatinons, department's activities, product information.
|   |
FDA - News Website contains index and searchable database of publications
|   |
National Center for Biotechnology Information (NCBI) at NLM A national resource for molecular biology information, NCBI creates public databases, conducts research in computational biology, develops software tools for analyzing genome data, and disseminates biomedical information.
|   |
EUDRA The European system for the authorisation of medicinal products for human and veterinary use is designed to promote both public health and the free circulation of pharmaceuticals
|   |
Health Services/Technology Assessment National Library of Medicine, searchable database
|   |
Office of Generic Drugs Petition Tracking The following is a list of Petitions filed, where the Agency determines the suitability or unsuitability of the product.
|   |
Prescription and Over-the-Counter Drug Product List CDER Document: additions/deletions for prescription drug product list.
|   |
World Health Organization Statistical Information System Health and health-related statistical information from the WHO Global Programme on Evidence for Health Policy
|   |
Division of Drug Marketing, Advertising and Communications (4/4/2000) To protect the public health by assuring prescription drug information is truthful, balanced, and accurately communicated.
|   |
CDER Phone Directory Office of Generic Drugs Phone Directory
|   |
Department of Health and Human Services The United States government's principal agency for protecting the health of all Americans and providing essential human services, especially for those who are least able to help themselves. The department contains over 300 programs, and the sit.
|   |
FDA Drug Approvals List Service by CDER's Division of Data Management and Services. The Drug approvals on this list are verified and published as they become available and at any given time may not contain all FDA drug approvals.
|   |
Center for Veterinary Medicine Regulates the manufacture and distribution of food additives and drugs that will be given to animals
|   |
Agency for Health Care Policy and Research AHRQ, part of the U.S. Department of Health and Human Services, is the lead agency charged with supporting research designed to improve the quality of health care, reduce its cost, and broaden access to essential services.
|   |
|
|